Abstract
Unlike lithium, chronic rubidium does not prevent the halopridol-induced increase in spiperone binding. Moreover, unlike other antidepressants, chronic rubidium does not reduce dihydroalprenolol binding.
| Original language | English |
|---|---|
| Pages (from-to) | 281-283 |
| Number of pages | 3 |
| Journal | Neuropsychobiology |
| Volume | 8 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1982 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Chronic rubidium does not prevent dopamine receptor supersensitivity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver